Showing results (1401-1410 of 6,713) with videos related to
Sort By:
Pageof 672
Oncotargets and Therapy|November 29, 2017
Clinical significance of CMTM4 expression in hepatocellular carcinomaChunhua Bei, Ying Zhang, Riming Wei, et al.Oncotargets and Therapy|November 29, 2017
Nimotuzumab combined with concurrent chemoradiotherapy benefits patients with advanced nasopharyngeal carcinomaZhanzhan Li, Yanyan Li, Shipeng Yan, et al.Oncotargets and Therapy|November 29, 2017
Curcumin potentiates the potent antitumor activity of ACNU against glioblastoma by suppressing the PI3K/AKT and NF-κB/COX-2 signaling pathwaysJun Zhao, Jiabin Zhu, Xiaoshu Lv, et al.Oncotargets and Therapy|December 26, 2017
High expression of CIP2A protein is associated with tumor aggressiveness in stage I-III NSCLC and correlates with poor prognosisGeqi Cha, Jianyu Xu, Xiangying Xu, et al.Oncotargets and Therapy|December 12, 2017
The combination therapy of salinomycin and gefitinib using poly(d,l-lactic-co-glycolic acid)-poly(ethylene glycol) nanoparticles for targeting both lung cancer stem cells and cancer cellsYu Zhang, Qi Zhang, Jing Sun, et al.Oncotargets and Therapy|December 12, 2017
The combination of systemic therapy and locoregional radiotherapy prolongs survival in newly diagnosed metastatic nasopharyngeal carcinoma patientsZhenzhen Yin, Ximei Zhang, Youyou Wang, et al.Oncotargets and Therapy|December 12, 2017
PBX3 is associated with proliferation and poor prognosis in patients with cervical cancerHongfang Li, Gaogao Sun, Chang Liu, et al.Oncotargets and Therapy|December 20, 2017
Impact of aristolochic acid exposure on oncologic outcomes of upper tract urothelial carcinoma after radical nephroureterectomyWenlong Zhong, Lei Zhang, Jiajian Ma, et al.Oncotargets and Therapy|December 5, 2017
The crossroads of breast cancer progression: insights into the modulation of major signaling pathwaysFernando J Velloso, Arthur Fr Bianco, Jessica O Farias, et al.Pageof 672